drugset / Trial / NCT03018704

Topiramate Treatment of Alcohol Use Disorders in African Americans

NCT03018704

Phase 4 Terminated 79 enrolled VA Office of Research and Development
RandomizedParallel-groupDouble-blindTreatment

Summary

The focus of this application is on the improvement of services for African American (AAs) Veterans afflicted with an alcohol use disorder. The project focuses on the use of topiramate as a treatment for alcohol use disorders. Despite having lower rates of heavy drinking than European Americans (EAs), AAs have significantly higher rates of mortality from a variety of alcohol-related conditions, including liver cirrhosis, accidents, and violence. Despite the higher rates of morbidity and mortality, pharmacological treatments are understudied in this population and there is some evidence that medications are less preferred and less effective in AAs.

Timeline

Start
2017-08-01
Primary completion
2021-12-31
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 200 mg Oral